United Therapeutics Corporation (UTHR)

United Therapeutics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for United Therapeutics stock have an average target of 370.86, with a low estimate of 280 and a high estimate of 600. The average target predicts a decrease of -2.92% from the current stock price of 382.01.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$280	$370.86	$370	$600
Change	-26.70%	-2.92%	-3.14%	+57.06%

Analyst Ratings

The average analyst rating for UTHR stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	2	4	3	4	6	6
Buy	7	6	6	6	6	5
Hold	1	2	2	2	2	2
Sell	0	0	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	10	12	12	13	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Chris Shibutani Goldman Sachs	Goldman Sachs	Hold Maintains $243 → $302	Hold	Maintains	$243 → $302	-20.94%	Nov 1, 2024
Matthew Kaplan Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Maintains $319 → $344	Strong Buy	Maintains	$319 → $344	-9.95%	Oct 31, 2024
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains $575 → $600	Buy	Maintains	$575 → $600	+57.06%	Oct 31, 2024
Jasper Hellweg Argus Research	Argus Research	Strong Buy Maintains $360 → $400	Strong Buy	Maintains	$360 → $400	+4.71%	Oct 31, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $400 → $425	Strong Buy	Maintains	$400 → $425	+11.25%	Oct 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.89B

Increased by 24.17%

from 2.33B

Revenue Next Year

3.15B

Increased by 9.10%

from 2.89B

EPS This Year

25.30

Increased by 27.72%

from 19.81

EPS Next Year

28.37

Increased by 12.14%

from 25.30

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.45B	1.48B	1.69B	1.94B	2.33B	2.89B	3.15B	3.37B
Revenue Growth	-11.00%	2.38%	13.63%	14.88%	20.20%	24.17%	9.10%	6.76%
EPS	-2.39	11.54	10.06	15.00	19.81	25.30	28.37	28.40
EPS Growth	-	-	-12.82%	49.11%	32.07%	27.72%	12.14%	0.08%
Forward PE	-	-	-	-	-	15.10	13.46	13.45
No. Analysts	-	-	-	-	-	18	18	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	3.0B	3.5B	3.8B
Avg	2.9B	3.2B	3.4B
Low	2.7B	2.7B	2.7B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	31.0%	21.2%	19.8%
Avg	24.2%	9.1%	6.8%
Low	15.3%	-6.1%	-14.1%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	28.63	37.64	33.86
Avg	25.30	28.37	28.40
Low	21.15	21.08	15.91

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	44.5%	48.8%	19.3%
Avg	27.7%	12.1%	0.1%
Low	6.8%	-16.7%	-43.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.